Hepatitis C virus (HCV) is a hepatotropic RNA virus that causes progressive liver damage,
which might result in liver cirrhosis and hepatocellular carcinoma. Globally, between 64 and …

Hepatitis C virus (HCV) is one of the leading causes of chronic liver disease, cirrhosis, and
hepatocellular carcinoma, resulting in major global public health concerns. The HCV …

Hepatocellular carcinoma (HCC) is a global health challenge. Due to the high prevalence in
low-income countries, hepatitis B virus (HBV) and hepatitis C virus infections remain the …

The advent of interferon-free direct-acting antiviral therapy for hepatitis C virus (HCV)
infection has heightened discussion of treatment as prevention. Rapid scale-up in many …

The total number, morbidity and mortality attributed to viraemic hepatitis C virus (HCV)
infections change over time making it difficult to compare reported estimates from different …

Hepatitis C virus (HCV) infection, defined by active carriage of HCV RNA, affects nearly
1.0% of the worldwide population. The main risk factors include unsafe injection drug use …

Results We found 44 studies from 12 countries in EMRO and the Middle East. HCC cases
from Iran, Lebanon, Turkey and Yemen were mainly due to HBV, while those of North …

Summary In 2015, the Coalition to Eradicate Viral Hepatitis in Asia Pacific gathered leading
hepatitis experts from Bangladesh, India, Indonesia, Malaysia, Pakistan, the Philippines, and …

Abstract Introduction The World Health Organization targets for hepatitis C virus (HCV)
elimination include a 90% reduction in new infections by 2030. Our objective is to review the …

Objectives To provide more accurate estimates of the prevalence of Hepatitis B (HBV) and
Hepatitis C (HCV) and their contributing factors among prisoners in Iran. Methods Cross …